Konrad Koehler

Konrad Koehler has a diverse work experience spanning several companies and roles in the pharmaceutical and biotechnology industry. Konrad began their career as a Research Scientist at G. D. Searle & Company in 1986. Konrad then moved on to become a Project Leader at IRBM (Merck Research Laboratories Italia) from 1993 to 1996. Following that, they joined Karo Bio AB as a Principal Scientist from 1996 to 2015. During this time, they also worked as a Senior Scientist at Solvay Pharmaceuticals from 2006 to 2008. In 2015, Koehler took on the role of Principal Scientist at Beactica AB, where they worked until 2020. In August 2020, they were promoted to the position of Head of Discovery at Beactica AB. Additionally, Koehler co-founded Immunscape AB in 2016 and continues to hold the position of Co-Founder there.

Konrad Koehler started their education in 1976 at the University of Wisconsin-Madison, where they pursued a Bachelor of Science degree in Chemistry and Biochemistry. Konrad completed their undergraduate studies in 1980.

After obtaining their bachelor's degree, Konrad enrolled at Emory University from 1980 to 1984. During this period, they pursued a Ph.D. in Organic Chemistry.

Following their Ph.D., Konrad attended Stanford University from 1984 to 1986 as a post-doctoral student. Konrad focused on furthering their knowledge in the field of Organic Chemistry during this period.